Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Thomas M. Lancaster0
Todd C. Zion0
Date of Patent
June 7, 2022
0Patent Application Number
171143950
Date Filed
December 7, 2020
0Patent Citations
Patent Citations Received
Patent Primary Examiner
The present disclosure provides recombinantly manufactured ultra-long acting insulin-Fc fusion proteins for use in treating diabetes. The insulin-Fc fusion proteins comprise an insulin polypeptide linked via a peptide linker to an Fc-fragment of human origin. Exemplary ultra-long acting insulin-Fc fusion proteins, polynucleotides encoding these insulin-Fc fusion proteins, and pharmaceutical formulations of exemplary insulin-Fc fusion proteins are provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
